AK Medical Holdings Limited reported a minor adjustment to its share capital following an on-market repurchase executed on 28 September 2026 under its existing mandate.

On the trading day, the company bought back 50,000 ordinary shares on the Hong Kong Stock Exchange at a single price of HK$4.84 per share, for a total consideration of HK$0.24 million. All repurchased shares have been retained as treasury stock.

Post-transaction, the number of issued shares (excluding treasury shares) declined marginally by 0.0046 % to 1.08 billion, while treasury shares rose to 32.72 million. Total issued shares remained unchanged at 1.11 billion.

The repurchase forms part of the mandate approved on 17 June 2026, which authorises AK Medical to reacquire up to 112.46 million shares. Cumulative repurchases under this mandate have reached 48.29 million shares, equivalent to 4.29 % of the company’s issued share capital on the mandate date.

In line with Hong Kong listing regulations, a moratorium is in place preventing AK Medical from issuing, selling or transferring shares until 28 October 2026.